Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.
anti-resorptive treatment
bisphosphonates
bone density
bone density conservation agents
bone fractures
glucocorticoid-induced osteoporosis
glucocorticoids
teriparatide
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
02
2022
accepted:
23
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
[This corrects the article DOI: 10.3389/fendo.2021.782118.].
Identifiants
pubmed: 35370960
doi: 10.3389/fendo.2022.877512
pmc: PMC8964402
doi:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
877512Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright © 2022 Hayes, Baschant, Hauser, Burden and Winter.